March 19, 2020
As the impact of the novel coronavirus disease (COVID-19) continues, we at Fitch Even recognize that you and your loved ones are coping with adjustments necessitated by the pandemic, just as we are. Our thoughts are with all those around the world who are affected by the outbreak now or will be in future days.
As we continue to monitor the COVID-19 situation and adhere to CDC and other governmental guidelines, our paramount concern is the well-being of our professionals, families, clients, and the communities in which we live and work. Accordingly, we have put measures in place that help to ensure safety for our people while we continue to seamlessly serve our clients' legal and business needs.
Our firm is fully operational with our people working remotely for the time being. Our attorneys and teams have the support, technology, and capacity to serve our clients and continue operations on an uninterrupted basis. All our internal systems and files can be accessed remotely through a secure network. This access includes our paperless file system and all research and filing tools. Our state-of-the-art IT infrastructure is maintained 24/7 by our IT professionals.
In short, your calls and emails are being answered, meetings are being held by audio or video conferencing, and we will continue to provide you with the same responsive counsel and exceptional work product you expect and deserve.
Thank you for your ongoing trust in Fitch Even. We look forward to working with you to address and overcome these current challenges. Please do not hesitate to reach out to us if we can be of any assistance. As always, we are here for you.
Mark W. Hetzler
Fitch, Even, Tabin & Flannery LLP
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more